Registry of Lobbyists
| Subject matters | Details | Categories |
|---|---|---|
|
Health, Science and Technology
|
Canada Agency for Drugs and Technologies in Health (CADTH) as it relates to health economics assessment and recommendations made on new medicines.
|
Policies or Program
|
|
Aboriginal Affairs, Health
|
Federal Government First Nations and Inuit Health Branch program with respect to health services. Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.
|
Policies or Program
|
|
Economic Development, Employment and Training, Health, Industry, Intellectual Property, Research and Development, Science and Technology
|
Innovation Agenda, particularly with respect to initiatives to support and attract investments in the life sciences sector
|
Policies or Program
|
|
Health, Industry, Intellectual Property, International Trade, Research and Development, Science and Technology
|
Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations
Patented Medicine Prices Review Board (PMPRB) Regulations with regard to reporting requirements, pricing, guidelines and dispute resolution.
|
Legislative Proposal, Bill or Resolution, Regulation
|
|
Aboriginal Affairs, Health, Immigration, Industry, Research and Development, Science and Technology
|
Policy and Programs
Health Canada and Public Health Agency of Canada policies and programs to prevent and treat HIV and eliminate hepatitis as a public health threat by 2030, as part of Canada's commitments under the Global Viral Hepatitis Strategy and therapeutic efforts against the fight for COVID-19.
|
Policies or Program
|
Gilead Sciences Canada Inc. is the Canadian affiliate of Gilead Sciences inc. Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet need. The company has a focus within the HIV, hepatitis, antiviral agents for pandemic response for COVID-19, inflammatory diseases, oncology and respiratory therapeutic areas.
Christophe Griolet, V.P. and General Manager
Address:
6925 Century Avenue, suite 400
Mississauga, ON L5N 7K2
Canada
Telephone number:
416-919-6379
Gilead Sciences Canada does not have any subsidiaries that could have a direct interest in the outcome of the undertaking